{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=diagnostic+procedure&page=2", "query": { "intervention": "diagnostic procedure", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=diagnostic+procedure&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-24T01:32:26.715Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05434936", "title": "Ovarian Tissue Cryopreservation for Fertility Preservation in Girls and Women", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fertility Preservation" ], "interventions": [ { "name": "Oophorectomy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "42 Years", "sex": "FEMALE", "summary": "0 Years to 42 Years · Female only" }, "enrollment_count": 24, "start_date": "2017-08-11", "completion_date": "2027-10-10", "has_results": false, "last_update_posted_date": "2023-06-18", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05434936" }, { "nct_id": "NCT02531607", "title": "Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pancreatic Neoplasms" ], "interventions": [ { "name": "blood and bile", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "AdventHealth", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "19 Years to 95 Years" }, "enrollment_count": 500, "start_date": "2014-11-13", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-02-05", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02531607" }, { "nct_id": "NCT05874726", "title": "Biological Sample Repository for Gastrointestinal Disorders", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity", "Obesity, Morbid", "Obesity, Primary", "Gastro-Intestinal Disorder", "Overweight and Obesity", "Overweight", "Overweight or Obesity", "Diabetes Type 2", "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Hypertension", "Hyperlipidemias", "Sleep Apnea", "GERD", "Gastroesophageal Reflux", "Musculoskeletal Pain Disorder", "Cancer" ], "interventions": [ { "name": "Blood Collection", "type": "DIAGNOSTIC_TEST" }, { "name": "Urine Collection", "type": "DIAGNOSTIC_TEST" }, { "name": "Tissue Sample Collection", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Pichamol Jirapinyo, MD, MPH", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2023-07-19", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2025-12-02", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05874726" }, { "nct_id": "NCT05433389", "title": "App Delivered Brief Mindfulness Intervention for Surgical Patients", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Anxiety State", "Depressive State" ], "interventions": [ { "name": "Breath Counting", "type": "BEHAVIORAL" }, { "name": "Body Scan", "type": "BEHAVIORAL" }, { "name": "Mindful Breathing", "type": "BEHAVIORAL" }, { "name": "Mindfulness of Pain", "type": "BEHAVIORAL" }, { "name": "Mindful Savoring", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 823, "start_date": "2022-06-21", "completion_date": "2025-11-01", "has_results": false, "last_update_posted_date": "2025-06-17", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05433389" }, { "nct_id": "NCT05376878", "title": "An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Anatomic Stage IV Breast Cancer AJCC v8", "Metastatic Breast Carcinoma", "Metastatic Malignant Neoplasm in the Brain" ], "interventions": [ { "name": "Copper Cu 64-DOTA-Trastuzumab", "type": "OTHER" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "DEVICE" }, { "name": "Trastuzumab", "type": "BIOLOGICAL" }, { "name": "Trastuzumab Deruxtecan", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "PROCEDURE", "DEVICE", "BIOLOGICAL" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2022-12-21", "completion_date": "2027-04-27", "has_results": false, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05376878" }, { "nct_id": "NCT05468008", "title": "Endoscopic Submucosal Dissection (ESD)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Esophageal Lesion", "Barrett Esophagus", "Gastrointestinal Lesions" ], "interventions": [ { "name": "Endoscopic Submucosal Dissection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "AdventHealth", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2022-02-04", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-02-02", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05468008" }, { "nct_id": "NCT00735917", "title": "Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Adenocarcinoma of the Pancreas", "Recurrent Pancreatic Cancer", "Stage IV Pancreatic Cancer" ], "interventions": [ { "name": "saracatinib", "type": "DRUG" }, { "name": "pharmacogenomic studies", "type": "OTHER" }, { "name": "pharmacological study", "type": "OTHER" }, { "name": "positron emission tomography", "type": "PROCEDURE" }, { "name": "fludeoxyglucose F 18", "type": "RADIATION" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2008-10", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2019-04-02", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 7, "location_summary": "Scottsdale, Arizona • Aurora, Colorado • Jacksonville, Florida + 4 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00735917" }, { "nct_id": "NCT03115450", "title": "Comparison of Pupilometer and Ultrasound of Optic Nerve Sheath Diameter in Estimating Intracranial Pressure (ICP)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Intracranial Hemorrhages", "Brain Injuries", "Subarachnoid Hemorrhage", "Ischemic Stroke", "Stroke" ], "interventions": [ { "name": "Ultrasound", "type": "DEVICE" }, { "name": "Pupilometer", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Loma Linda University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2018-04-01", "completion_date": "2018-06-15", "has_results": false, "last_update_posted_date": "2021-10-26", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "Loma Linda, California", "locations": [ { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03115450" }, { "nct_id": "NCT06042543", "title": "Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cervical Cancer", "Screening" ], "interventions": [ { "name": "Screening with HPV test", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "International Agency for Research on Cancer", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "25 Years to 49 Years · Female only" }, "enrollment_count": 3200, "start_date": "2023-12-09", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-06-01", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06042543" }, { "nct_id": "NCT03709043", "title": "Addressing Heavy Alcohol Use Consumption With Kudzu", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol Use Disorder", "Sexually Transmitted Diseases" ], "interventions": [ { "name": "Standardized kudzu", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Sexually transmitted infection testing:", "type": "DIAGNOSTIC_TEST" }, { "name": "Medical Management (MM) counseling for alcohol use:", "type": "BEHAVIORAL" }, { "name": "Urinalysis for novel alcohol biochemical markers for recent alcohol use:", "type": "DIAGNOSTIC_TEST" }, { "name": "Dried Blood Spot (DBS) Testing for PEth:", "type": "DIAGNOSTIC_TEST" }, { "name": "Behavioral survey measurements:", "type": "BEHAVIORAL" }, { "name": "Ecological Momentary Assessment procedure:", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "OTHER", "DIAGNOSTIC_TEST", "BEHAVIORAL" ], "sponsor": "Glenn-Milo Santos", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 120, "start_date": "2019-07-11", "completion_date": "2024-06-01", "has_results": true, "last_update_posted_date": "2026-05-01", "last_synced_at": "2026-09-24T01:32:26.715Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03709043" } ] }